FDA warning letter
Issue date
20 Apr 2023
Issuing office
Division of Pharmaceutical Quality Operations III
Posted date
25 Apr 2023
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Accra Pac
Manufacturer
Warning letter
Headquarters
IndiaSites
United States of America